Alzheimer Disease : Rehabilitation's Intervention at Home (pré MATAPA)
Alzheimer Disease : Rehabilitation's Intervention at Home. A Preliminary Pilot Study.
Alzheimer's disease (AD) is the most common cause of dementia among elderly patients. By its prevalence and its medical and social consequences, AD represents a dual challenge to public health and society. The elderly want to stay in their homes even when their lives are altered by a chronic progressive disease. Their caregivers claim in turn a support at home. But this desire is questioned because of the characteristics of the disease, e.g. the altered relational function by the cognitive impairment and the behavioural disorders associated.
Outpatients non-drug therapies represent a potential support that adapts to patient with an AD or mixed dementia, especially in their milder forms.
The aim of the study is to evaluate the feasibility of a weekly rehabilitation's intervention at home and its acceptability by both the patient and the caregiver.
The study of its efficiency in terms of autonomy will be the next step.
調査の概要
詳細な説明
The protocol is based on weekly rehabilitation's intervention at home. All home visits and assessments of the patient and his caregiver will be made by the rehabilitation's therapist himself.
Twelve weekly interventions at home are planed. The first five are needed to define a realistic and achievable goal of treatment which is accepted by the dyad and the therapist. The following seven interventions will achieve this goal by rehabilitation's intervention (e.g. occupational therapy, psychomotor approach).
Four filmed sessions for dyad's assessment are planned (at inclusion, at weeks 5 and 12 after inclusion and 3 months after the last intervention).
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Nantes、フランス、44093
- Bellier Hospital, CHU of Nantes
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Patient's inclusion criteria:
- Aged 65 and over
- AD or mixed dementia (DSM IV TR criteria), documented by a neuropsychological assessment and a brain imaging
- Living at home
- Having a caregiver (more than 2 visits per week)
- Agreement for the study
Caregiver's inclusion criteria :
- More than 2 patient's visits per week
- Agreement for the study
Patient's exclusion criteria:
- Life expectancy less than 1 year
- Guardianship
- Already having a rehabilitation program's therapy
- Participation in a pharmacological study
Caregiver's exclusion criteria:
- Medical condition requiring regular care
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
実験的:Home rehabilitation therapy
12 weekly sessions of Home rehabilitation therapy
|
12 sessions of home rehabilitation therapy
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Evaluation of the mean scores of Instrumental Activities of Daily Living (IADL)
時間枠:27 weeks
|
The main objective is to compare the mean scores of Instrumental Activities of Daily Living (IADL) observed at inclusion (day 0) with those observed 27 weeks later (meaning 3 months after the last of the twelfth weekly session of at home rehabilitation therapy).
|
27 weeks
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Evaluation of the mean scores of Instrumental Activities of Daily Living (IADL)
時間枠:5 weeks
|
This objective is to compare the mean scores of Instrumental Activities of Daily Living (IADL) observed at inclusion (day 0) with those observed 5 weeks later (meaning after the fifth weekly session of at home rehabilitation therapy).
|
5 weeks
|
Evaluation of the mean scores of Instrumental Activities of Daily Living (IADL)
時間枠:13 weeks
|
This objective is to compare the mean scores of Instrumental Activities of Daily Living (IADL) observed at inclusion (day 0) with those observed 13 weeks later (meaning after the twelfth weekly session of at home rehabilitation therapy).
|
13 weeks
|
Evaluation of the mean scores of Neuro Psychiatric Inventory (NPI)
時間枠:27 weeks
|
This objective is to compare the mean scores of Neuro Psychiatric Inventory(NPI) observed at inclusion (day 0) with those observed 27 weeks later (meaning 3 months after the last of the twelfth weekly session of at home rehabilitation therapy).
|
27 weeks
|
Evaluation of the mean scores of Neuro Psychiatric Inventory (NPI)
時間枠:5 weeks
|
This objective is to compare the mean scores of Neuro Psychiatric Inventory(NPI) observed at inclusion (day 0) with those observed 5 weeks later (meaning after the last of the fifth weekly session of at home rehabilitation therapy).
|
5 weeks
|
Evaluation of the mean scores of Neuro Psychiatric Inventory (NPI)
時間枠:13 weeks
|
This objective is to compare the mean scores of Neuro Psychiatric Inventory(NPI) observed at inclusion (day 0) with those observed 12 weeks later (meaning after the last of the twelfth weekly session of at home rehabilitation therapy).
|
13 weeks
|
Evaluation of the mean scores of Zarit's scale (caregiver burden)
時間枠:13 weeks
|
This objective is to compare the mean scores of Zarit's scale observed at inclusion (day 0) with those observed 13 weeks later (meaning after the twelfth weekly session of at home rehabilitation therapy).
|
13 weeks
|
Evaluation of the mean scores of Zarit's scale (caregiver burden)
時間枠:27 weeks
|
This objective is to compare the mean scores of Zarit's scale observed at inclusion (day 0) with those observed 27 weeks later (meaning 3 months after the last of the twelfth weekly session of at home rehabilitation therapy).
|
27 weeks
|
Evaluation of the mean scores of Zarit's scale (caregiver burden)
時間枠:5 weeks
|
This objective is to compare the mean scores of Zarit's scale observed at inclusion (day 0) with those observed 5 weeks later (meaning after the last of the fifth weekly session of at home rehabilitation therapy).
|
5 weeks
|
Alcohol consumption for the patient and the caregiver
時間枠:27 weeks
|
This objective is to compare the alcohol consumption for the patient and the caregiver observed at inclusion (day 0) with those observed 27 weeks later (meaning 3 months after the last of the twelfth weekly session of at home rehabilitation therapy).
|
27 weeks
|
Evaluation of the mean scores of Mini Mental State Examination (MMSE)(meaning evaluation of patient's cognitive impairment)
時間枠:27 weeks
|
This objective is to compare the mean scores of Mini Mental State Examination (MMSE) observed at inclusion (day 0) with those observed 27 weeks later (meaning 3 months after the last of the twelfth weekly session of at home rehabilitation therapy).
|
27 weeks
|
Evaluation of the mean scores of Goal Attainment scales (GAS) (meaning evaluation of the satisfaction of the patient and of her/his caregiver)
時間枠:27 weeks
|
This objective is to compare the mean scores of Goal Attainment Scales (GAS) observed at inclusion (day 0) with those observed 27 weeks later (meaning 3 months after the last of the twelfth weekly session of at home rehabilitation therapy).
|
27 weeks
|
協力者と研究者
捜査官
- 主任研究者:Gilles Berrut, Pr、Bellier Hospital, CHU of Nantes
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
アルツハイマー病の臨床試験
-
Adelphi Values LLCBlueprint Medicines Corporation完了肥満細胞性白血病 (MCL) | 攻撃的な全身性肥満細胞症 (ASM) | SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD) | くすぶり全身性肥満細胞症 (SSM) | 無痛性全身性肥満細胞症 (ISM) ISM サブグループが完全に募集されましたアメリカ
Home rehabilitation therapyの臨床試験
-
University Health Network, TorontoSunnybrook Health Sciences Centre; University of Toronto積極的、募集していない
-
Universitätsklinikum Hamburg-EppendorfCytoSorbents, Inc募集
-
University of Michigan完了
-
University Health Network, Toronto募集リンパ腫 | リンパ増殖性疾患 | 乳がんステージ I | 乳がんステージ II | 大腸がんステージ II | 結腸直腸がん III期 | 乳がんステージ III | 結腸直腸がんステージ I | 頭頸部がん III期 | 乳がん、ステージ0 | 頭頸部がんステージ I | 頭頸部がんステージ IIカナダ
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); Allina Health System; Minneapolis Heart Institute...完了